University Hospitals, Case Medical Center
Cleveland, Ohio, 44106, United States
NCT Number: NCT00553436
The purpose of this study is to show that the surgical site in the bowel wall can be sewn closed in the colon or intestine, with a new sewing device after removal of a benign polyp according to standard of care.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44106, United States
Polypectomy is the medical term for removing polyps. Polyps are abnormal like growths that protrude into the lining of the bowel. Because a polyp cannot always be removed by a snare, the usual and simplest method, (for example, it may be too flat), a doctor (colorectal surgeon) may perform a polypectomy using a technique called Endoscopic Mucosal Resection (EMR). Endoscopic Mucosal Resection (EMR)is based on the concept that endoscopy (looking at the inside of your colon with an instrument called a colonoscope) provides visualization and access to the innermost lining of the gastrointestinal tract, where a polyp originates. The Endoscopic Mucosal Resection (EMR)performed during this study will be standard of care according to the current practice at University Hospitals of Cleveland.
Following polyp removal, the study procedure will be performed. A medical device is being evaluated to help with this procedure by closing the wound that remains after the polyp is removed without performing an open surgical operation. This involves suturing (sewing) the tissue back together with a Tissue Apposition System (TAS). This is also called tissue approximation. The sewing device being evaluated has been cleared by the Food and Drug Administration (FDA).
Up to 20 men and women, at least 21 years of age, requiring removal of a colonic or rectal polyp that cannot be removed by traditional colonic polypectomy, will be asked to enroll in the study. Following polyp removal, these patients will have the remaining tissue area closed using the study sewing device. Participation in this study will last approximately three months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Closure of defect following polypectomy using the Tissue Apposition System (TAS) Device.
Time frame: At The Time of Surgery
Number of enrolled subjects (participants) treated with successful deployment of the Tissue Apposition System (TAS) device.
Time frame: 3 month follow-up
The total number of participants with successful deployments of tissue anchors and associated knotting elements for tissue closure post-Endoscopic Mucosal Resection (EMR) tissue apposition and achieving defect closure.
Time frame: 3 month follow-up
Ethicon Endo-Surgery
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04889352
Colo-rectal Cancer, Colon Polyp
Winnipeg, Manitoba, Canada
View Trial DetailsNCT04325815
Adenoma Colon, Colon Polyp
London, United Kingdom
View Trial DetailsNCT02831556
Abdominal Injuries, Adnexal Diseases
Durham, North Carolina, United States
View Trial DetailsNCT01820182
Anemia, Angiodysplasia
View Trial Details